Recovery Resources & Insights

Addiction Information

Santa Clara's Fentanyl Reality: What Local Data and Families Are Telling Us

By Dr. Priya Ramachandran, Medical Director · Published February 2026 · 9 min read

Santa Clara County reported a sharp increase in synthetic-opioid-related fatalities between 2020 and 2024, and our admissions intake data at IBRP mirrors what the county data shows. Fentanyl is no longer an East Coast problem, a homeless-encampment problem, or a problem that only affects people who previously used heroin. In the last calendar year at our facility, nearly one in three admissions for "opioid use" turned out, on toxicology, to involve fentanyl — often in pills the patient believed to be oxycodone, Xanax, or Adderall.

This matters for families in Santa Clara for a specific reason. The conversation parents and partners used to have — "are you using drugs?" — is now a conversation about drug supply. A young person who takes what they believe to be a single Percocet at a party can encounter a fatal dose of fentanyl in that one pill. There is no slow slide, no warning sign, no history of use required. The clinical response has to match that reality.

Practically, this means three things for Santa Clara families. First, naloxone — the overdose-reversal medication Narcan — should be in every household that contains anyone who uses any substance recreationally, even casually. It is available without a prescription at CVS, Walgreens, and county health offices. Second, fentanyl test strips are legal, cheap, and available through Santa Clara County public health harm-reduction programs. Third, if a family member's behavior suggests substance use, the clinically honest answer is to call an admissions specialist sooner rather than later — the escalation curve is no longer months or years, it is weeks.

Family Support

When Love Starts Enabling: Codependency Patterns in Santa Clara Households

By Jordan Asante, LMFT, Clinical Director · Published December 2025 · 8 min read

The word "codependency" has been worn down by overuse, which is a pity, because the underlying clinical pattern is real and almost universal in families living with addiction. In the therapy rooms at IBRP, we see it the same way, over and over: a loving spouse, parent, sibling, or adult child who has organized their entire life around managing someone else's substance use — hiding bottles, covering at work, calling in sick on behalf of the person who is using, keeping the family secret through school events and holidays and work promotions. These are acts of love. They are also, clinically, acts that extend the addiction by absorbing its consequences.

The shift that has to happen — and it is a wrenching one — is from "managing the using" to "letting the consequences land where they belong." That does not mean abandonment, and it does not mean tough-love theater. It means stopping the quiet work that keeps the addiction invisible to the outside world. Our family programming runs every Thursday and includes a specific codependency-pattern workshop for partners and parents, drawn from clinical models but taught in plain language, with the explicit goal of helping family members understand why letting go of control often produces better outcomes than tightening it.

If you are a family member reading this and recognizing yourself, the most important thing to know is that you have not caused the addiction, and you cannot cure it — but you can stop being the system that absorbs its consequences, and that change alone often opens space for the using person to seek treatment. Our family coordinator runs a free weekly consultation call for Santa Clara-area families whether or not their loved one is a patient at IBRP.

Dual Diagnosis

When Depression and Addiction Collide: Dual Diagnosis Care in Santa Clara

By the IBRP Clinical Team · Published October 2025 · 10 min read

Roughly seven out of every ten patients who come to IBRP for addiction treatment also carry a second diagnosis — most commonly depression, anxiety, PTSD, bipolar disorder, or ADHD. For years, the conventional clinical wisdom was to "treat the addiction first" and address the co-occurring condition afterward. That approach produced worse outcomes than the integrated alternative, and the evidence base has moved on. Good care now treats both, in parallel, from day one.

Depression is the most common co-occurring condition we see, and it interacts with substance use in a way that is easy to miss. The patient has often been using the substance to manage depressive symptoms, which means that early sobriety — without the substance as a buffer — can bring a sharp increase in depressive affect. Left unaddressed, that is one of the single most reliable paths to early relapse. Our psychiatric team reviews every admission within 48 hours, adjusts medication as clinically appropriate, and coordinates with the therapy staff so that the depression treatment advances alongside the addiction work rather than behind it.

For Santa Clara patients specifically: many arrive on an SSRI or SNRI that was prescribed years ago by a primary care physician and never seriously reviewed. One of the first things our psychiatrist does is examine whether the current medication is actually doing what it was prescribed to do, whether dosing is optimal, and whether a change — sometimes a simple one — would meaningfully improve how the patient feels in the first weeks of sobriety. Good psychiatric care in the first month of recovery is one of the strongest predictors of long-term outcome we see in our data.